Preclinical Development of a Fusion Peptide Conjugate as an HIV Vaccine Immunogen
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Preclinical Development of a Fusion Peptide Conjugate as an HIV Vaccine Immunogen
Authors
Keywords
-
Journal
Scientific Reports
Volume 10, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-02-20
DOI
10.1038/s41598-020-59711-y
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Antibody Lineages with Vaccine-Induced Antigen-Binding Hotspots Develop Broad HIV Neutralization
- (2019) Rui Kong et al. CELL
- Conformational Plasticity in the HIV-1 Fusion Peptide Facilitates Recognition by Broadly Neutralizing Antibodies
- (2019) Meng Yuan et al. Cell Host & Microbe
- Consistent elicitation of cross-clade HIV-neutralizing responses achieved in guinea pigs after fusion peptide priming by repetitive envelope trimer boosting
- (2019) Cheng Cheng et al. PLoS One
- The phenyl linker markedly increases the immunogenicity of the pneumococcal polysaccharide conjugate vaccine
- (2018) Dong Wei et al. BIOTECHNOLOGY LETTERS
- Epitope-based vaccine design yields fusion peptide-directed antibodies that neutralize diverse strains of HIV-1
- (2018) Kai Xu et al. NATURE MEDICINE
- Safety, tolerability and immunogenicity of intramuscular administration of PRP-CRM 197 Hib vaccine to healthy Japanese children: An open-label trial
- (2018) Takehiro Togashi et al. VACCINE
- A cross-reacting material CRM 197 conjugate vaccine induces diphtheria toxin neutralizing antibody response in children and adolescents infected or not with HIV
- (2017) Giselle P. Silva et al. VACCINE
- Monitoring of dynamic changes in Keyhole Limpet Hemocyanin (KLH)-specific B cells in KLH-vaccinated cancer patients
- (2017) Florian Wimmers et al. Scientific Reports
- Safety profile of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV)
- (2016) Sven Arne Silfverdal et al. Expert Review of Vaccines
- A retrospective analysis of the Alzheimer's disease vaccine progress - The critical need for new development strategies
- (2016) Dante J. Marciani JOURNAL OF NEUROCHEMISTRY
- Cryo-EM structure of a native, fully glycosylated, cleaved HIV-1 envelope trimer
- (2016) J. H. Lee et al. SCIENCE
- Fusion peptide of HIV-1 as a site of vulnerability to neutralizing antibody
- (2016) R. Kong et al. SCIENCE
- Peptide-based synthetic vaccines
- (2016) Mariusz Skwarczynski et al. Chemical Science
- An HIV-1 antibody from an elite neutralizer implicates the fusion peptide as a site of vulnerability
- (2016) Marit J. van Gils et al. Nature Microbiology
- Recent advances in the molecular design of synthetic vaccines
- (2015) Lyn H. Jones Nature Chemistry
- Viral membrane fusion
- (2015) Stephen C. Harrison VIROLOGY
- A Cholera Conjugate Vaccine Containing O-specific Polysaccharide (OSP) of V. cholerae O1 Inaba and Recombinant Fragment of Tetanus Toxin Heavy Chain (OSP:rTTHc) Induces Serum, Memory and Lamina Proprial Responses against OSP and Is Protective in Mice
- (2015) Md. Abu Sayeed et al. PLoS Neglected Tropical Diseases
- Structural Delineation of a Quaternary, Cleavage-Dependent Epitope at the gp41-gp120 Interface on Intact HIV-1 Env Trimers
- (2014) Claudia Blattner et al. IMMUNITY
- Structure and immune recognition of trimeric pre-fusion HIV-1 Env
- (2014) Marie Pancera et al. NATURE
- Evaluation in Mice of a Conjugate Vaccine for Cholera Made from Vibrio cholerae O1 (Ogawa) O-Specific Polysaccharide
- (2014) Mohammad Murshid Alam et al. PLoS Neglected Tropical Diseases
- Chemoenzymatic synthesis of immunogenic meningococcal group C polysialic acid-tetanus Hc fragment glycoconjugates
- (2013) Pumtiwitt C. McCarthy et al. GLYCOCONJUGATE JOURNAL
- Protein carriers of conjugate vaccines: Characteristics, development and clinical trials
- (2013) Michael E Pichichero Human Vaccines & Immunotherapeutics
- Safety and Immunogenicity of a Quadrivalent Meningococcal Polysaccharide Diphtheria Toxoid Conjugate Vaccine in Infants and Toddlers
- (2012) L. Miriam Pina et al. PEDIATRIC INFECTIOUS DISEASE JOURNAL
- Structural basis for lack of toxicity of the diphtheria toxin mutant CRM197
- (2012) E. Malito et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The immunogenicity and safety of an investigational meningococcal serogroups A, C, W-135 and Y tetanus toxoid conjugate vaccine (ACWY-TT) compared with a licensed meningococcal tetravalent polysaccharide vaccine
- (2012) Ghassan Dbaibo et al. Human Vaccines & Immunotherapeutics
- Comparative effects of carrier proteins on vaccine-induced immune response
- (2011) Markus Knuf et al. VACCINE
- A tetravalent meningococcal serogroups A, C, W-135, and Y tetanus toxoid conjugate vaccine is immunogenic and well-tolerated when co-administered with Twinrix® in subjects aged 11–17 years: An open, randomised, controlled trial
- (2011) Lars Østergaard et al. VACCINE
- Multimeric bivalent immunogens from recombinant tetanus toxin HC fragment, synthetic hexasaccharides, and a glycopeptide adjuvant
- (2009) Aileen F. G. Bongat et al. GLYCOCONJUGATE JOURNAL
- Immunogenicity of Routinely Used Childhood Vaccines When Coadministered With the 10-Valent Pneumococcal Non-typeable Haemophilus influenzae Protein D Conjugate Vaccine (PHiD-CV)
- (2009) Markus Knuf et al. PEDIATRIC INFECTIOUS DISEASE JOURNAL
- Keyhole Limpet Hemocyanin: 9-Å CryoEM Structure and Molecular Model of the KLH1 Didecamer Reveal the Interfaces and Intricate Topology of the 160 Functional Units
- (2008) Christos Gatsogiannis et al. JOURNAL OF MOLECULAR BIOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More